The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada
|
|||||
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada. . . . → Read More: Moderna to Build mRNA Vaccine Plant in Canada Medical researchers are assessing the feasibility of a wearable device to detect advance indicators of chronic respiratory disease symptoms. . . . → Read More: Univ. Lab Testing Wearable Respiratory Monitor A new business accelerator program is underway to nurture start-up companies applying computational techniques to the life sciences and health care. . . . → Read More: Computational Health Incubator Opens in Seattle A synthetic antibody is shown in lab tests to neutralize variants of the SARS-CoV-2 virus, and will be added to an ongoing clinical trial of Covid-19 therapies. . . . → Read More: Antibody Clears Covid-19 Variants, Enters Trial Two companies with alternative techniques for manufacturing concrete won a challenge competition to convert carbon dioxide into useful products. . . . → Read More: Concrete Mfring Processes Win CO2 Conversion Challenge Clinical trial results show a hospital bed that simulates contact with a mothers’ body helps preterm babies cope with unpleasant medical procedures. . . . → Read More: Intensive Care Bed Designed for Preterm Babies A clinical trial is set to begin that tests a treatment for early-stage breast cancer delivered directly into the tumor before surgery is scheduled. . . . → Read More: Clinical Trial Tests In-Tumor Breast Cancer Therapy Researchers in Canada developed a simple and inexpensive test for Covid-19 antibodies requiring a pinprick of blood, and returning results in under an hour. . . . → Read More: Fast, Inexpensive Covid-19 Immunity Test Devised CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil. . . . → Read More: CEPI Funding SARS-CoV-2 Variant Vaccines A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections. . . . → Read More: Trial Testing Multi-Company Covid-19 Therapy |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |